Vivien Chan
15Patents
7h-index
29Co-inventors
66Inventor score
Filing activity: Aug 17, 2000 → Feb 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7501244B2 | Determining prognosis of colon or breast cancer by measuring TTK expression | Physics | 77 | Expired |
| US6703221B1 | Notch receptor ligands and uses thereof | Chemistry; Metallurgy | 39 | Expired |
| US7279554B2 | Notch receptor ligands and uses thereof | Chemistry; Metallurgy | 34 | Expired |
| US7700359B2 | Gene products differentially expressed in cancerous cells | Chemistry; Metallurgy | 27 | Expired |
| US10098951B2 | Antibody/T-cell receptor chimeric constructs and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10464988B2 | Antibody/T-cell receptor chimeric constructs and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10822389B2 | Antibody/T-cell receptor chimeric constructs and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US7501242B2 | Detection of colon or breast cancer by measuring TTK polynucleotide expression | Physics | 3 | Expired |
| US11421013B2 | Antibody/T-cell receptor chimeric constructs and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US7501243B2 | Detection of colon or breast cancer by measuring TTK polypeptide expression | Physics | 1 | Expired |
| US8299081B2 | Methods for treating drug resistant cancer | Human Necessities | 1 | Active |
| US8221983B2 | Gene products differentially expressed in cancerous cells | Chemistry; Metallurgy | 0 | Active |
| US11274157B2 | Constructs targeting histone H3 peptide/MHC complexes and uses thereof | Physics | 0 | Active |
| US7867731B2 | HX2004-6 polypeptide expressed in cancerous cells | Physics | 0 | Active |
| US11976105B2 | Antibody/T-cell receptor chimeric constructs and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.